Skip to main content
Start Project

Free field guide · PDF

ISO 14155:20262026 Field Guide

The edition clock, the six changes, and the consent bar — with the GCP practice you need.

Effective
Apr 26
Transition
No
Changes
6

Sourced from verified 2026 publications.

Download the free guide

Enter your work email and we'll send the PDF straight to your inbox.

Professional review is required before business use. See our privacy policy.

What's inside

Five pages, zero fluff

Every figure in this guide traces to a named source — verified 2026 publications.

The edition clock

The edition clock: effective Apr 26, 2026, no transition period — ongoing studies need review now.

The six changes

The six changes: risk management, CECs, DMCs, study design & statistics, informed consent, AE reporting.

The consent bar

The consent bar: ample deliberation, plain language, device-specific information, implant-card provisions.

Sources & scope

  • clinicaltrialsbc.ca, ISO 14155 Clinical Investigation of Medical Devices for Humans published.
  • blog.ansi.org, ISO 14155:2026 — Clinical Investigation of Medical Devices.
  • meddeviceguide.com, GCP for Medical Device Clinical Trials (ISO 14155 and ICH E6(R3) in 2026).

This guide is market-access intelligence, not regulatory or legal advice. ISO 14155 interpretation, ethics-committee requirements, and national rules change — professional review is required before business use.

Market Access Strategy Session

Clinical evidence on your 2026 roadmap? Start with the full picture.

A Market Access Strategy Session maps your evidence route — investigation strategy, GCP planning, and global evidence positioning.

Professional review is required before business use.